Inventor
SHIVELY JOHN E
US26 patents
⚠️ This page may combine multiple inventors who share the name “SHIVELY JOHN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOPE CITY
20 patentsUS7776330B2Aug 17, 2010
Humanized anti-CEA T84.66 antibody and uses thereof
HOPE CITY25 citations90
US5081235AJan 14, 1992
Chimeric anti-cea antibody
HOPE CITY40 citations90
US5075431ADec 24, 1991
Chimeric anti-CEA antibody
HOPE CITY25 citations90
US7273608B2Sep 25, 2007
Humanized anti-CEA T84.66 antibody and uses thereof
HOPE CITY10 citations82
US5137695AAug 11, 1992
Apparatus for the sequential performance of chemical processes
HOPE CITY21 citations77
US5861125AJan 19, 1999
Protein or peptide sequencing method and apparatus
HOPE CITY12 citations73
US5061635AOct 29, 1991
Protein or peptide sequencing method
HOPE CITY6 citations73
US5432092AJul 11, 1995
C-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridine
HOPE CITY13 citations72
US5180807AJan 19, 1993
C-terminal peptide or protein sequencing reagent and method
HOPE CITY14 citations72
US5432093AJul 11, 1995
Sequential degradation of proteins and peptides from the N-terminus
HOPE CITY6 citations61
US5432091AJul 11, 1995
N-terminal sequencing of proteins and peptides
HOPE CITY4 citations61
US11541062B2Jan 3, 2023
Methods of treating advanced prostate cancer
HOPE CITY0 citations60
US10603328B2Mar 31, 2020
Methods of treating advanced prostate cancer
HOPE CITY1 citations60
US5227309AJul 13, 1993
C-terminal peptide sequencing method
HOPE CITY5 citations57
US12043673B2Jul 23, 2024
Complementary RNA linked bispecific T-cell engaging antibodies
HOPE CITY0 citations55
US5998213ADec 7, 1999
C-terminal sequencing of peptides which may include proline
HOPE CITY0 citations51
US5986071ANov 16, 1999
Method for C-terminal degradation of peptides and proteins
HOPE CITY1 citations51
US5541114AJul 30, 1996
Sequencing of protein immobilized on polytetrafluoroethylene supports
HOPE CITY1 citations51
US5525707AJun 11, 1996
N-terminal peptide degradation utilizing dialkylthiocarbamoylhalides
HOPE CITY0 citations51
US9005969B2Apr 14, 2015
Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes
HOPE CITY0 citations48